Milton C. Ault III - Jan 5, 2024 Form 4 Insider Report for Alzamend Neuro, Inc. (ALZN)

Role
Director, 10%+ Owner
Signature
/s/ Milton C. Ault, III
Stock symbol
ALZN
Transactions as of
Jan 5, 2024
Transactions value $
$5,093
Form type
4
Date filed
1/9/2024, 04:30 PM
Previous filing
Dec 27, 2023
Next filing
Apr 19, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALZN Common Stock Purchase $5.09K +5K +0.65% $1.02 768K Jan 5, 2024 By Ault Lending, LLC F1, F2
holding ALZN Common Stock 167K Jan 5, 2024 Direct
holding ALZN Common Stock 996K Jan 5, 2024 By Ault Life Sciences, Inc. F3
holding ALZN Common Stock 667K Jan 5, 2024 By Ault Life Sciences Fund, LLC F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 26,032 shares of common stock previously owned by, and received from, Ault Alpha LP ("Ault Alpha"), in connection with the liquidation of Ault Alpha on December 28, 2023. Those 26,032 shares were previously reported as beneficially owned by Mr. Ault as Ault Alpha also reported as an indirect beneficial ownership under Mr. Ault, so no change in beneficial ownership of those shares occurred in connection with the liquidation.
F2 Ault Lending, LLC ("Ault Lending"), is a wholly-owned subsidiary of Ault Alliance, Inc. ("AAI"). Mr. Ault, the Executive Chairman of AAI, is deemed to have voting and investment power with respect to the securities held of record by Ault Lending.
F3 Mr. Ault has sole voting and investment power with respect to the securities held of record by Ault Life Sciences, Inc.
F4 Mr. Ault has sole voting and investment power with respect to the securities held of record by Ault Life Sciences Fund, LLC.